PatientsVille.com Logo

Diverticulitis and Ciprofloxacin

PatientsVille

Diverticulitis Symptoms and Causes

Diverticula are small pouches that bulge outward through the colon, or large intestine. If you have these pouches, you have a condition called diverticulosis. It becomes more common as people age. About half of all people over age 60 have it. Doctors believe the main cause is a low-fiber diet.

Most people with diverticulosis don't have symptoms. Sometimes it causes mild cramps, bloating or constipation. Diverticulosis is often found through tests ordered for something else. For example, it is often found during a colonoscopy to screen for cancer. A high-fiber diet and mild pain reliever will often relieve symptoms.

If the pouches become inflamed or infected, you have a condition called Diverticulitis. The most common symptom is abdominal pain, usually on the left side. You may also have fever, nausea, vomiting, chills, cramping, and constipation. In serious cases, Diverticulitis can lead to bleeding, tears, or blockages. Your doctor will do a physical exam and imaging tests to diagnose it. Treatment may include antibiotics, pain relievers, and a liquid diet. A serious case may require a hospital stay or surgery.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for diverticulitis

diverticulitis treatment research studies

Ciprofloxacin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Ciprofloxacin Side Effects

Arthralgia (550)
Pain In Extremity (389)
Tendonitis (280)
Diarrhoea (274)
Pyrexia (260)
Renal Failure Acute (240)
Tendon Pain (237)
Dizziness (236)
Headache (234)
Anxiety (233)
Myalgia (229)
Nausea (225)
Pain (225)
Paraesthesia (219)
Insomnia (208)
Fatigue (204)
Rash (202)
Gait Disturbance (196)
Confusional State (187)
Tendon Rupture (174)
Asthenia (173)
Hypoaesthesia (168)
Pruritus (165)
Vomiting (163)
Dyspnoea (159)
Oedema Peripheral (147)
Muscular Weakness (140)
Muscle Spasms (132)
Abdominal Pain (129)
Neuropathy Peripheral (128)
Back Pain (127)
Burning Sensation (126)
International Normalised Ratio Increased (126)
Erythema (124)
Tendon Disorder (121)
Malaise (113)
Depression (112)
Feeling Abnormal (110)
Urticaria (109)
Musculoskeletal Pain (107)
Chest Pain (105)
Joint Swelling (104)
Convulsion (99)
Condition Aggravated (98)
Sepsis (94)
Agitation (94)
Tinnitus (93)
Abasia (93)
Palpitations (93)
Urinary Tract Infection (89)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I have been taking ciprofloxacina for an stomacal infection. It has worked well, I feel much better but I have experienced dizziness (a lot of dizziness).

side effects of ciprofloxacine on strocke patients

After a couple of days on Cipro, I started to have hallucinations. I remembered yellow dots and other figures. So bad that I had to change meds.

DOES CIPROFLOXACI CAUSE DEATH OR IT SOME RELATED ISSNESS

Effects of ciprofloxacin on CVA patients

Elderly patient with IT and massive mastoid sinusitis being treated with vancomycin/cipro IV duo. Side effects???

Heyyy

How long are cipro bags good for once removed from the outer wrap?

I am 17 years old and im taking ciprofloxacin for my kidney infection, and at first i thought i was just being silly but i started to see things and like now it is more intense.like things are there them gone and like untill recently it hasn't bother

I am a female was 65 years of age when given cipro for an infection. I developed PMR immediately after was so stiff I could not even push the gas pedal in my car-Here I am almost three years later and I still h

I AM CURRENTLY TAKING CIPRO FOR A BOUT OF DIVERTICULITIS. I HAVE MUSCLE WEAKNESS JOINT PAIN,JAW,NECK AND SHOULDERS AND FIND MY STOMACH TO HURT TWICE AS BAD. I BELIEVE THIS IS A SIDE AFFECT I QUITE TAKING THE CIPRO FOR ONE DOSE AND THE STOMA

I had no diagnosis of any diverticulosis or diverticulitis prior to April 7 2010. That night I was working afternoon turn when severe abdominal pain struck and at first I thought I had apendicitis but the pain was so severe I had no idea how I got ho

I have had horrible stomach problems since taking Rocephin. BLOATING was off the charts. PAIN, and irritable bowel and diverticulitis was set off to a huge degree. The bloating is somewhat bettr, but I'm homebound with stomach pain and gas and

II take it for diverticulitis & it eased the spasms dramatically after just 2 pills!! I had been in agony , rolling around floor for days suffering before finally ringing my G.P because I am on so many other pills for other illnesses &amp

My mother has taken Avastin for small cell lung cancer for the past year and now being hospitalized for severe diverticulitis.

My mum suffers with diverticulitis and over the past eight months has suffered a great deal of stomach pain and has had numerous tests ,she had a barium enama and since then has been really ill ,loss of appetite ,wieght loss,and severe depression ple

Prescribed avelox for diverticulitis. took 1 400mg tab yesterday and experienced some very disturbing side effects. took another today (absolutely my last dose) and it was horrible. major anxiety, confusion, pain, tinnitus, tingling in extremeties,

The exact same thing happened to me after I was prescribed high dose flagyl for 5 days for suspected diverticulitis (painful bloating, frothy yellow diarrhea, excessive foul gas, etc.) my doc also put me on a Clear Liquid Diet for 3 days before I h

Well i got diverticulitis from accutane and i would rather just have used proactive now. i didnt get my symptoms when i was taking it. but a few years later. so vanessa i really hope you dont have to experience it.

Diverticulitis Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
Condition: Otitis Externa
Interventions: Drug: Cipro HC;   Drug: Ciprofloxacin HCl and Hydrocortisone
Outcome Measures: Cure (reduced pain, swelling and otorrhea);   Identification of possible side effects
2 Recruiting Ciprofloxacin for Prevention of BK Infection
Condition: BK Virus Infection
Interventions: Drug: Ciprofloxacin;   Drug: placebo
Outcome Measures: BK infection at 6 months post-transplant;   Incidence of urinary tract infections as defined by a midstream urine sample containing 10^4 or more colony-forming units per mL;   Incidence of bacteremic infections at 6 months. Incidence of bacteremia as defined by a single positive blood culture that was not thought to be contaminated.;   Incidence of quinolone-resistant bacterial infections;   Incidence of clostridium difficile infection;   Serious adverse events;   Time to BK infection;   Proportion of patients developing BK infection at 1 year;   First and peak plasma viral loads;   Incidence of acute rejection at 1 year;   Incidence and severity of BK nephropathy, as defined by positive staining of histopathological specimen, at 1 year
3 Recruiting Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin: administered for 28 days on / 28 days off;   Drug: Placebo: administered for 28 days on / 28 days off;   Drug: Ciprofloxacin: administered for 14 days on / 14 days off;   Drug: Placebo: administered for 14 days on / 14 days off
Outcome Measures: Time to first exacerbation;   Mean number of exacerbations per patient per 48 weeks;   Pathogens present at baseline and eradicated at 48 weeks;   Quality of Life: Changes of Saint George's Respiratory;   New pathogens at 48 weeks, not present at baseline;   Changes of Forced Expiratory Volume in 1 second from baseline;   Number of participants with Adverse events as a measure of
4 Recruiting Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention
Condition: Adverse Reaction to Other Drugs and Medicines
Interventions: Drug: Norfloxacin;   Drug: Ciprofloxacin
Outcome Measures: The prevention rate of spontaneous bacterial peritonitis (SBP);   1 year mortality;   Incidence of infectious event other than SBP;   Hepatorenal syndrome;   Hepatic encephalopathy;   Adverse event of drugs
5 Recruiting Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin DPI (BAYQ3939);   Drug: Placebo
Outcome Measures: Time to first exacerbation;   Mean number of exacerbations per patient per 48 weeks;   Pathogens present at baseline and eradicated at 48 weeks;   Changes of Saint George's Respiratory Questionnaire score from baseline to 48 weeks;   New pathogens at 48 weeks, not present at baseline;   Changes of Forced expiratory volume in 1 second from baseline to 48 weeks;   Number of participants with Adverse events as a measure of safety and tolerability
6 Recruiting Population Pharmacokinetics of Anti-infectious Drugs in Children
Conditions: Pediatrics;   Ceftazidime;   Ciprofloxacin;   Voriconazole
Interventions: Drug: Ceftazidime;   Drug: Ciprofloxacin;   Drug: Voriconazole
Outcome Measures: Population pharmacokinetic parameters and factors explaining variability;   Covariability factors explaining the variability (age, biological data, pharmacokinetics factors, associated treatments...)
7 Recruiting Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes
Condition: Otitis Media in Patients With Tympanostomy Tubes.
Interventions: Drug: Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension;   Drug: CIPRODEX® (Ciprofloxacin 0.3%/dexamethasone 0.1%);   Drug: Placebo Sterile Otic Suspension
Outcome Measures: Clinical Success;   Cessation of Otorrhea
8 Unknown  TINN Pharmacokinetics (PK) Study Treat Infections iN Neonates
Condition: Pharmacokinetics of Ciprofloxacin in Neonates
Intervention: Procedure: Collection of biological samples
Outcome Measures: Ciprofloxacin plasma concentration and population pharmacokinetic (PK) parameters;   PK variables;   Tolerability;   Safety;   Clinical/microbiological outcomes
9 Not yet recruiting Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
Conditions: Healthy Volunteers;   Non-smokers
Interventions: Drug: Pracinostat;   Drug: Itraconazole;   Drug: Ciprofloxacin
Outcome Measures: Peak plasma concentration Cmax in healthy nonsmoking subjects given a single-dose of pracinostat;   Number of participants with Adverse Events as a measure of safety and tolerability of single-dose pracinostat when administered with itraconazole or with Ciprofloxacin in healthy nonsmoking adult subjects.;   Peak plasma PK concentration Area Under the Curve (AUC)AUC 0-t, AUC 0-inf in healthy nonsmoking subjects given a single dose of pracinostat
10 Recruiting A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans
Condition: Plague
Interventions: Drug: Ciprofloxacin;   Drug: doxyxcycline
Outcome Measures: all cause mortality;   time to defervesence;   antimicrobial associated adverse events
11 Recruiting Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy
Condition: Urinary Tract Infections
Interventions: Drug: Fosfomycin 3 g;   Drug: Ciprofloxacin 500 mg
Outcome Measures: Bacteriuria;   Urinary Tract Infection;   Sepsis;   Pathogens present in urine and antimicrobial resistance;   Bacteremia;   Hematuria;   Hemospermia;   Rectal bleeding;   Urinary retention;   Difficulty for miction;   Genitourinary infections associated to fever (>38ºC);   Number of participants with adverse events
12 Recruiting A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Condition: Otitis Externa
Interventions: Drug: Ciprofloxacin/Dexamethasone;   Drug: Ciprodex (R);   Drug: Placebo
Outcome Measures: Clinical Success;   Resolution of Symptoms
13 Recruiting Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis
Condition: Non Cystic Fibrosis Bronchiectasis
Intervention: Drug: Ciprofloxacin
Outcome Measures: Time to first exacerbation;   Number of exacerbations
14 Unknown  Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: Ciprofloxacin;   Drug: cefepime
Outcome Measures: Treatment efficacy;   Toxicity
15 Recruiting Antibiotics and Hydroxychloroquine in Crohn's
Condition: Crohn's Disease
Interventions: Drug: Ciprofloxacin;   Drug: Doxycycline;   Drug: Hydroxychloroquine;   Drug: Budesonide
Outcome Measures: • Remission, defined as Crohn's Disease activity index (CDAI) <150 at 10 weeks without addition of any other medication or treatment for the Crohn's Disease.;   • Remission, defined as CDAI ≤150 maintained through to 24 weeks;   • Remission, defined as CDAI ≤150 maintained through to 52 weeks;   • Remission defined as CDAI <150 at 4 weeks;   • Response defined as a fall in CDAI by >70 points at 4 weeks and 10 weeks;   • Markers of cost (days admitted to hospital, days unable to carry out normal daily activities, need for surgery);   • Quality of life at 4 weeks, at 10 weeks, or Early Withdrawal;   • Patient global assessment of symptom severity by 10 cm visual analogue score at 4 weeks, at 10 weeks, or Early Withdrawal;   • Adverse Events and possible drug-related side effects: nausea, diarrhoea, mood disturbance, sleep disturbance - will all be assessed at each visit;   • Fall in Faecal Calprotectin
16 Recruiting Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Condition: Traveler's Diarrhea
Interventions: Drug: Rifamycin SV MMX;   Drug: Ciprofloxacin
Outcome Measures: Time to Last Unformed Stool (TLUS);   Clinical cure
17 Recruiting Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Conditions: SBP;   Liver Cirrhosis
Interventions: Drug: Cefotaxime;   Drug: Ceftriaxone;   Drug: Ciprofloxacin
Outcome Measures: Infection resolution rates within 5 days of treatment;   Infection resolution rates within 5 days;   Mortality & recurrence rates within 1 month
18 Recruiting BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
Conditions: HIV;   Salivary Gland Disease;   Benign Lymphoepithelial Lesion
Interventions: Drug: Ciprofloxacin;   Drug: Placebo
Outcome Measures: (BK) Virus replication and shedding;   Salivary function
19 Recruiting Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Conditions: Urinary Tract Infections;   Acute Pyelonephritis
Interventions: Drug: Finafloxacin 800 mg i.v. once daily;   Drug: Finafloxacin placebo i.v. once daily;   Drug: Finafloxacin 800 mg tablets (as four 200 mg tablets) once daily;   Drug: Finafloxacin placebo tablets (as four tablets) once daily;   Drug: Ciprofloxacin 400 mg i.v. two times daily;   Drug: Ciprofloxacin placebo i.v. two times daily;   Drug: Ciprofloxacin 500 mg oral (as two 250 mg capsules) two times daily;   Drug: Ciprofloxacin placebo oral (as two capsules each) two times daily
Outcome Measures: Clinical and microbiological response of patients with cUTI or pyelonephritis.;   The clinical and microbiological response at the On Therapy (OT) visit (Day 3).;   The clinical and microbiological response at the End of Therapy (EoT) visit (Day 10).;   The clinical and microbiological response at the End of Study (EoS) visit (Day 24).;   The safety and tolerability of multiple doses of finafloxacin of both 5 days and 10 days of treatment with finafloxacin (i.v. and oral) in subjects with cUTI, compared to 10 days of Ciprofloxacin (i.v. and oral).;   The predictive capacity of PK/PD data of both 5 days and 10 days of treatment with finafloxacin (i.v. and oral) in subjects with cUTI, using 10 days of Ciprofloxacin (i.v. and oral) as reference on clinical outcomes (EMA guidance).
20 Recruiting Antibiotic Prophylaxis in Laparoscopic Cholecystectomy
Condition: Cholelithiasis
Interventions: Drug: Ciprofloxacin;   Drug: Ampicillin-sulbactam;   Drug: Placebo
Outcome Measures: Surgical site infection;   Extra-abdominal infections;   Adverse events.;   Quality of life